TMDX Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages TransMedics Group, Inc. (NASDAQ: TMDX) Investors with Significant Losses to Contact the Firm

Core Viewpoint - Kessler Topaz Meltzer & Check, LLP is investigating potential violations of federal securities laws related to TransMedics Group, Inc. following allegations of fraudulent business practices and regulatory scrutiny [1][2]. Group 1: Allegations and Investigations - Scorpion Capital issued a report alleging that TransMedics engaged in fraudulent billing schemes, off-label misuse of devices, and relied on kickbacks to drive sales [2]. - The report also mentioned ongoing investigations by the DOJ, IRS, and state attorney generals concerning Medicare fraud linked to organ acquisition costs [2]. - Customer dissatisfaction was highlighted, with reports of prominent transplant centers discontinuing the use of TransMedics' devices due to concerns over their clinical value [2]. Group 2: Market Reaction - Following the allegations and report, TransMedics' stock price has decreased by more than 13% over multiple trading days [3].